个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ ESCI

作者：
Cui, Jiujie[1] ; Jiao, Feng[1] ; Li, Qi[5] ; Wang, Zheng[4] ; Fu, Deliang[6] ; Liang, Jun[7] ; Liang, Houjie[8,9] ; Xia, Tingyi[10,11] ; Zhang, Tao[12] ; Zhang, Yang[13] ; Dai, Guanghai[14] ; Zhang, Zhihong[15] ; Wang, Jian[16] ; Bai, Yongrui[17] ; Bai, Yuxian[18] ; Bi, Feng[19] ; Chen, Donghui[5] ; Cao, Dan[19] ; Chen, Jie[20] ; Fang, Weijia[21] ; Gao, Yong[22] ; Guo, Jianwei[23] ; Hao, Jihui[24] ; Hua, Haiqing[3] ; Huang, Xinyu[25] ; Liu, Wenchao[26] ; Liu, Xiufeng[3] ; Li, Da[27] ; Li, Ji[6] ; Li, Enxiao[28] ; Li, Zhiwei[29] ; Pan, Hongming[27] ; Shen, Lin[30] ; Sun, Yongwei[31] ; Tao, Min[32] ; Wang, Chengfeng[33,34] ; Wang, Fenghua[35] ; Xiong, Jianping[36] ; Zhang, Taiping[37] ; Zhang, Xuebin[38] ; Zhan, Xianbao[39] ; Zheng, Leizhen[40] ; Ren, Gang[41] ; Zhang, Tingting[18] ; Zhou, Jun[30] ; Ma, Qingyong[4] ; Qin, Shuku[3] ; Hao, Chunyi[2] ; Wang, Liwei[1] ;
机构： [1]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Med Oncol, Shanghai, Peoples R China [2]Peking Univ, Dept Hepatopancreatobiliary Surg, Canc Hosp, Beijing, Peoples R China [3]Eastern Theater Command Gen Hosp, Dept Med Oncol, Nanjing, Peoples R China [4]Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian, Peoples R China [5]Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Med Oncol, Shanghai, Peoples R China [6]Fudan Univ, Pancreat Dis Inst, Huashan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China [7]Peking Univ, Dept Oncol, Int Hosp, Beijing, Peoples R China [8]Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China [9]Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China [10]Air Force Gen Hosp, Beijing Huaxia Jingfang Canc Radiotherapy Ctr, Beijing, Peoples R China [11]Peoples Liberat Army Gen Hosp, Beijing, Peoples R China [12]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China [13]Dalian Med Univ, Dept Oncol, Affiliated Hosp 2, Dalian, Peoples R China [14]Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China [15]Nanjing Med Univ, Dept Pathol, Affiliated Hosp 1, Nanjing, Peoples R China [16]Naval Mil Med Univ, Changzheng Hosp, Dept Imaging, Shanghai, Peoples R China [17]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiat Oncol, Shanghai, Peoples R China [18]Harbin Med Univ, Oncol Dept Internal Med, Canc Hosp, Harbin, Peoples R China [19]Sichuan Univ, West China Hosp, Dept Med Oncol, Chengdu, Peoples R China [20]Chinese Acad Med Sci & Peking Union Med Coll, Dept Pathol, Peking Union Med Coll Hosp, Beijing, Peoples R China [21]Zhejiang Univ, Affiliated Hosp 1, Dept Med Oncol, Coll Med, Hangzhou, Peoples R China [22]Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China [23]Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China [24]Tianjin Med Univ Canc Inst & Hosp, Dept Pancreat Canc, Natl Clin Res Ctr Canc, Tianjin, Peoples R China [25]Shanghai Jiao Tong Univ, Dept Gen Surg, Affiliated Peoples Hosp 6, Shanghai, Peoples R China [26]Air Force Med Univ, Xijing Hosp, Dept Clin Oncol, Xian, Peoples R China [27]Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou, Peoples R China [28]Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Peoples R China [29]Harbin Med Univ, Dept Gastrointestinal Med Oncol, Canc Hosp, Harbin, Peoples R China [30]Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Canc Hosp & Inst,Minist Educ Beijing, Beijing, Peoples R China [31]Shanghai Jiao Tong Univ, Dept Biliary Pancreat Surg, Sch Med, Affiliated Renji Hosp, Shanghai, Peoples R China [32]Soochow Univ, Dept Oncol, Affiliated Hosp 1, Suzhou, Peoples R China [33]Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Mol Oncol, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China [34]Chinese Acad Med Sci & Peking Union Med Coll, Dept Pancreat & Gastr Surg, Natl Canc Ctr, Canc Hosp,Natl Clin Res Ctr Canc, Beijing, Peoples R China [35]Sun Yat Sen Univ, Dept Med Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China [36]Nanchang Univ, Dept Oncol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China [37]Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China [38]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Intervent Oncol, Shanghai, Peoples R China [39]Navy Med Univ, Changhai Hosp Shanghai, Dept Med Oncol, Shanghai, Peoples R China [40]Shanghai Jiao Tong Univ, Dept Oncol, Xin Hua Hosp, Sch Med, Shanghai, Peoples R China [41]Peking Univ, Shougang Hosp, Beijing, Peoples R China
出处：
DOI： 10.1016/j.jncc.2022.08.006

关键词： Pancreatic cancer Chinese society of clinical oncology Guidelines China

摘要：
Pancreatic cancer is one of the leading causes of cancer-related mortality in both developed and developing countries. The incidence of pancreatic cancer in China accounts for about a quater of the global incidence, and the epidemiological characteristics and therapeutic strategies differ due to social, economic, cultural, environmental, and public health factors. Non-domestic guidelines do not reflect the clinicopathologic characteristics and treatment patterns of Chinese patients. Thus, in 2018, the Chinese Society of Clinical Oncology (CSCO) organized a panel of senior experts from all sub-specialties within the field of pancreatic oncology to compile the Chinese guidelines for the diagnosis and treatment of pancreatic cancer. The guidelines were made based on both the Western and Eastern clinical evidence and updated every one or two years. The experts made consensus judgments and classified evidence-based recommendations into various grades according to the regional differences, the accessibility of diagnostic and treatment resources, and health economic indexes in China. Here we present the latest version of the guidelines, which covers the diagnosis, treatment, and follow-up of pancreatic cancer. The guidelines might standardize the diagnosis and treatment of pancreatic cancer in China and will encourage oncologists to design and conduct more clinical trials about pancreatic cancer.

基金：
Scientific and Technological Innovation Project of Science and Technology Commission of Shanghai Municipality [21JC1404300]; CSCO Clinical Oncology Research Foundation [Y-2019AZZD-0513]
语种：
外文
被引次数：
WOS：
PubmedID：
JCR分区：
出版当年[2022]版：
无
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Med Oncol, Shanghai, Peoples R China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Cui Jiujie,Jiao Feng,Li Qi,et al.Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer[J].Journal Of The National Cancer Center.2022,2(4):205-215.doi:10.1016/j.jncc.2022.08.006.
APA：
Cui, Jiujie,Jiao, Feng,Li, Qi,Wang, Zheng,Fu, Deliang...&Wang, Liwei.(2022).Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer.Journal Of The National Cancer Center,2,(4)
MLA：
Cui, Jiujie,et al."Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer".Journal Of The National Cancer Center 2..4(2022):205-215

相关文献

[1]The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. [2]The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023 [3]The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma. [4]The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma [5]Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations [6]2020年中国临床肿瘤学会《食管癌诊疗指南》解读 [7]Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology(Open Access) [8]Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) [9]肝癌AASLD、EASL、JSH指南及中国诊疗规范的比较 [10]Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号